• Bookmark and Share

Statement Issued About New Discovery

Last Updated on Friday, February 06, 2004

FEBRUARY 06, 2004 -  The Preeclampsia Foundation today issued a statement of cautious optimism about the new study to be published in next week's New England Journal of Medicine, indicating a unique protein marker is sharply elevated five weeks prior to the onset of preeclampsia.

Anne Garrett, Executive Director of the Preeclampsia Foundation, the nation's only patient advocacy organization dedicated to hypertensive disorders of pregnancy, said, "The study shows great promise that a definitive diagnostic tool could be developed to identify which pregnant women will develop this potentially life-threatening complication. While we are extremely excited that the cause of preeclampsia may have been discovered, a fact that has eluded medical experts for hundreds of years, we are especially hopeful that this may herald an increase in awareness and research funding for a cure. It is extremely important that science, academia and industry partner their resources to advance a proven therapy. The mortality rate from preeclampsia and related conditions for women and their babies is unacceptable.

 

UPCOMING EVENTS

We’ll be Speaking Here

 

Brevard County Women of Excellence Breakfast

April 21, 2015

 

Grand Rounds University of Chicago

May 15, 2015

 

Northside Hospital CME, Atlanta, GA

August 21, 2015

 

Invite Us to Speak at Your Event

 

Preeclampsia in the News

Featured Video

What’s Happening on Twitter

Preeclampsia Here's an interesting older article on one mechanism possibly connecting autoimmune conditions, and preeclampsia.... http://t.co/VqqET6sOT0
7hreplyretweetfavorite
Preeclampsia Why do you participate in the Promise Walk for Preeclampsia every year? What are your family/team's traditions?... http://t.co/ieD6fFMmhb
Preeclampsia *Note: Spoiler alert below for The Mindy Project* Preeclampsia survivor fans of The Mindy Project were... http://t.co/SyOQcdLyLn

Press Releases by Year

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.